FDA Premarket Cybersecurity Submission Checklist Guide

Ensure your 510(k) or PMA is compliant. Use our checklist for FDA premarket cybersecurity submissions, covering SBOM, threat models, and pen testing.

This guide is written for medical device manufacturers navigating FDA premarket cybersecurity submission checklist. It is built from real submissions, FDA correspondence, and the standards reviewers actually cite. Use it as a working reference: read straight through, jump to the section that matches your current gap, or hand it to your engineering and regulatory leads as a checklist.

Introduction to the FDA's Final Guidance on Cybersecurity

Introduction to the FDA's Final Guidance on Cybersecurity is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

The Impact of Section 524B of the FD&C Act

The Impact of Section 524B of the FD&C Act. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

What the FDA Expects in a 'Cyber-Secure' Submission

What the FDA Expects in a 'Cyber-Secure' Submission. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

The Pre-Submission Checklist: Essential Documentation

The Pre-Submission Checklist: Essential Documentation is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Cybersecurity Management Plan (CMP)

Cybersecurity Management Plan (CMP). Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Security Risk Management Report (SRMR)

Security Risk Management Report (SRMR). Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Software Bill of Materials (SBOM) Requirements

Software Bill of Materials (SBOM) Requirements. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Deep Dive: Security Risk Management Analysis

Deep Dive: Security Risk Management Analysis is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Threat Modeling Documentation (STRIDE/HEC)

Threat Modeling Documentation (STRIDE/HEC). Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Vulnerability Assessment and CVSS Scoring

Vulnerability Assessment and CVSS Scoring. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Risk Mitigation and Residual Risk Justification

Risk Mitigation and Residual Risk Justification. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Security Architecture and Design Documentation

Security Architecture and Design Documentation is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Data Flow Diagrams and Trust Boundaries

Data Flow Diagrams and Trust Boundaries. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Authentication and Encryption Controls

Authentication and Encryption Controls. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Cybersecurity Interface Control Documents

Cybersecurity Interface Control Documents. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Security Testing and Verification Requirements

Security Testing and Verification Requirements is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Vulnerability Scanning Results

Vulnerability Scanning Results. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Penetration Testing Summary Reports

Penetration Testing Summary Reports. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Anomaly and Robustness Testing (Fuzzing)

Anomaly and Robustness Testing (Fuzzing). Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Postmarket Management Documentation Strategy

Postmarket Management Documentation Strategy is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Vulnerability Disclosure Policy (VDP) Details

Vulnerability Disclosure Policy (VDP) Details. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Patch Management and Distribution Plans

Patch Management and Distribution Plans. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Common Pitfalls to Avoid in Premarket Submissions

Common Pitfalls to Avoid in Premarket Submissions is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Conclusion: Ensuring a Successful FDA Review Cycle

Conclusion: Ensuring a Successful FDA Review Cycle is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

How Blue Goat Cyber Approaches FDA premarket cybersecurity submission checklist

We treat FDA premarket cybersecurity submission checklist as a regulated engineering workstream, not a one-time document drop. Every engagement is led by senior medical-device security engineers who have shipped 250+ FDA cybersecurity submissions across 510(k), De Novo, PMA, and EU MDR pathways. Here is how we run it end to end:

• Scoping against your device profile. We baseline connectivity, interfaces, data flows, and intended use before we touch a template - because reviewer expectations for a Class II wearable are not the same as a networked hospital platform.
• Standards mapping in writing. Every deliverable is traced to the February 2026 FDA premarket cybersecurity guidance, AAMI SW96, AAMI TIR57 / TIR97, IEC 81001-5-1, and ISO 14971 - with the citation in the artifact itself so reviewers do not have to guess.
• Evidence generated inside your QMS. Threat models, SBOMs, security risk assessments, and test reports are versioned under design controls so the traceability from requirement → test → residual risk holds up under audit.
• Independent testing where it counts. Penetration testing and vulnerability analysis are executed by a testing team that does not also write the design - the separation FDA reviewers increasingly expect on cyber devices.
• Deficiency-ready posture. We anticipate the RTA, AI-letter, and Major deficiency patterns FDA has issued over the past 24 months and pre-empt them in the initial submission, cutting the odds of a second review cycle.
• Postmarket handoff, not abandonment. Every premarket package leaves you with a working postmarket monitoring plan, CVD process, and update cadence so the evidence you shipped stays defensible after clearance.

If you want that treatment applied to your FDA premarket cybersecurity submission checklist package, our FDA Premarket Cybersecurity Services and FDA Cybersecurity Deficiency Response engagements are the two most common entry points.

Where 21 CFR 807.81 fits in

21 CFR 807.81 is the procedural regulation that triggers a 510(k) premarket notification in the first place. If 807.81 applies to your device, and your device is a "cyber device" under Section 524B, the cybersecurity package described on this page must ship inside that 510(k). 807.81 tells you whether you file; Section 524B and the February 2026 final guidance tell you what cybersecurity evidence the filing must contain.

Frequently asked questions

Do you have a standalone article on 21 CFR 807.81?

No, and that is deliberate. 21 CFR 807.81 is a procedural 510(k) filing rule, not a cybersecurity requirement, so we cover it inline wherever it matters to a cyber submission rather than as its own post. For the cybersecurity content the 510(k) must carry, see the FDA 524B Cybersecurity Requirements guide and the "Where 21 CFR 807.81 fits in" section above.

What are the minimum cybersecurity requirements for an FDA 510(k)?

Short answer: FDA premarket cybersecurity submission checklist is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

Does the FDA require penetration testing for all medical devices?

Short answer: Yes. Under Section 524B and the February 2026 final guidance, every cyber device requires the artifact in question. Skipping it is the fastest way to an RTA hold. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What SBOM format does the FDA prefer?

Short answer: It depends on the device classification, intended use, and connectivity profile. But the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How do I document threat modeling in a premarket submission?

Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What is the 'Refuse to Accept' (RTA) policy for cybersecurity?

Short answer: FDA premarket cybersecurity submission checklist is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How often should cybersecurity testing be updated before submission?

Short answer: It depends on the device classification, intended use, and connectivity profile. But the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

Where this fits in the cluster

This page sits downstream of our pillar resources on FDA premarket cybersecurity submission checklist. If you arrived here from a different starting point, these are the most useful adjacent pages:

• FDA Premarket Cybersecurity Services
• FDA Cybersecurity Deficiency Response
• 12 Reasons the FDA Rejects Medical Device Cybersecurity Submissions
• The MedTech Cybersecurity Standards Decoder

Related from Blue Goat Cyber

• Medical Device Threat Modeling
• Medical Device Penetration Testing
• FDA-Compliant SBOM Services
• The SPDF Playbook for FDA-Ready Medical Devices
• FDA Cybersecurity Deficiency Letter Response Checklist

Sources & primary references

• Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions. U.S. Food and Drug Administration (FDA)
• Framework for Improving Critical Infrastructure Cybersecurity (Cybersecurity Framework). NIST
• SW96:2023 Medical devices - Security risk management - Application of ISO 14971. AAMI/ANSI
• Select Updates for Non-Clinical Tests and Software Considerations in Premarket Submissions. U.S. Food and Drug Administration (FDA)

Talk to a regulatory cybersecurity team

If you are working through FDA premarket cybersecurity submission checklist and want a second pair of eyes on your submission package, we ship cybersecurity deliverables for medical device manufacturers across 510(k), De Novo, PMA, and EU MDR pathways. Book a discovery session and we will walk your evidence with you.